EN
登录

美国疾病控制与预防中心敦促美国旅客在全球麻疹病例上升之际接种MMR疫苗

CDC Urges U.S. Travelers to Get MMR Vaccine Amid Rising Measles Cases Globally

GeneOnline 等信源发布 2025-06-07 17:15

可切换为仅中文


by Mark Chiang

由马克·蒋

Share To

分享到

The Centers for Disease Control and Prevention (CDC) is advising all U.S. travelers to ensure they are vaccinated against measles, mumps, and rubella (MMR) in response to an increase in measles cases. The agency highlights the importance of immunization as a preventive measure to address ongoing outbreaks and reduce the risk of transmission during international travel..

美国疾病控制与预防中心 (CDC) 建议所有美国旅行者确保接种麻疹、腮腺炎和风疹 (MMR) 疫苗,以应对麻疹病例的增加。该机构强调了免疫作为预防措施的重要性,以应对持续的疫情并降低国际旅行期间传播的风险。

According to the CDC, recent data indicates a rise in reported measles cases both domestically and globally. Measles is a highly contagious viral disease that can lead to severe complications, including pneumonia, encephalitis, and death. The CDC emphasizes that vaccination remains the most effective method of protection against the disease.

根据疾控中心数据,近期麻疹病例在国内和全球范围内均呈现上升趋势。麻疹是一种高度传染的病毒性疾病,可能导致严重并发症,包括肺炎、脑炎甚至死亡。疾控中心强调,接种疫苗仍然是预防该疾病最有效的方法。

Travelers who are not fully vaccinated or lack immunity are at higher risk of contracting measles while abroad and potentially spreading it upon their return. The agency recommends that individuals planning international trips verify their vaccination status and receive the MMR vaccine if necessary before departure..

未完全接种疫苗或缺乏免疫力的旅行者在出国期间感染麻疹的风险较高,并可能在回国后传播该疾病。该机构建议计划国际旅行的人士确认自己的疫苗接种情况,并在必要时在出发前接种麻腮风三联疫苗。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源:GO-AI-ne1

Date: June 5, 2025

日期:2025年6月5日

Related posts:

相关文章:

Antibody-based therapy is several steps closer to treat lethal mucormycosis

基于抗体的疗法在治疗致命性毛霉菌病方面又向前推进了几步。

Abundance of key immune cells may be influenced by estrogen and XX chromosomes

关键免疫细胞的丰度可能受雌激素和XX染色体的影响

Generic Drug Market to Reach $1 Trillion by 2025 Amidst Patent Expirations and Regulatory Hurdles.

仿制药市场将在专利到期和监管障碍中于2025年达到1万亿美元。

European Biosimilar Market to Reach $10.4 Billion by 2025, Fueled by 34.6% CAGR

欧洲生物仿制药市场将在2025年达到104亿美元,年均复合增长率为34.6%。

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 保留所有权利。与我们合作:

[email protected]

电子邮件地址

Author

作者

Mark Chiang

马克·蒋

Related Post

相关文章

News Flash

新闻快讯

USP Announces Plans for Advanced Technologies Laboratory to Promote Modern Pharmaceutical Manufacturing Techniques

美国药典宣布计划建立先进技术实验室,以推动现代制药技术的发展。

2025-06-07

2025年6月7日